MAGE-A9 Inhibitors
Chemical inhibitors of MAGE-A9 function through various interactions with histone deacetylases (HDACs), enzymes that remove acetyl groups from histone proteins, leading to a more compact chromatin structure and reduced gene expression. Vorinostat (also known as SAHA or Suberoylanilide Hydroxamic Acid), Romidepsin, Entinostat (also referred to as MS-275), Belinostat, Panobinostat, Chidamide, Valproic acid, Sodium butyrate, and Mocetinostat all inhibit HDAC activity. By doing so, these chemicals can cause an increase in acetylated histones, which is associated with a more open chromatin structure. However, the specific inhibition of MAGE-A9 by these chemicals occurs when the altered chromatin configuration suppresses the expression of MAGE-A9, thus inhibiting its protein function. This suppression is not due to a decrease in mRNA synthesis but rather the result of transcriptional repression through chromatin remodeling.
The inhibition of HDACs leads to an accumulation of acetylated histones, which can then interfere with the ability of transcription factors or other protein complexes that regulate MAGE-A9 to access the DNA, thereby reducing the activity of MAGE-A9. For example, Vorinostat and Panobinostat are broad-spectrum HDAC inhibitors that change the level of gene expression by altering the chromatin landscape, which can result in the inhibition of MAGE-A9. More selective inhibitors like Entinostat target specific classes of HDACs, potentially offering a more targeted approach to suppress MAGE-A9 expression. Valproic acid and Sodium butyrate, while also being HDAC inhibitors, have a broader range of biological effects, yet their role in inhibiting MAGE-A9 comes from the same fundamental mechanism of disrupting chromatin structure to repress gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat functions as an HDAC inhibitor, potentially leading to increased acetylation of histones, which may suppress the expression of MAGE-A9 by remodeling chromatin to a more closed configuration, inhibiting the protein's function. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
As an HDAC inhibitor, Romidepsin could increase histone acetylation, potentially leading to a decrease in MAGE-A9 expression by modifying chromatin architecture, thereby inhibiting the protein's activity. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits class I HDACs, which could lead to altered acetylation of histones, potentially suppressing MAGE-A9 expression by changing chromatin structure, resulting in functional inhibition of the protein. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
By inhibiting HDACs, Belinostat could cause hyperacetylation of histones, potentially leading to downregulation of MAGE-A9 by modifying the chromatin conformation, which inhibits its functional activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat serves as an HDAC inhibitor, possibly leading to changes in histone acetylation, which may reduce expression of MAGE-A9 by altering the chromatin landscape, resulting in inhibition of the protein's function. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
As an HDAC inhibitor, Chidamide may increase acetylation of histones, potentially decreasing MAGE-A9 expression by remodeling chromatin into a less accessible state, thereby inhibiting the protein's activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, an HDAC inhibitor, could lead to an increase in histone acetylation, potentially resulting in decreased MAGE-A9 expression by changing the chromatin structure, which could inhibit the functional activity of the protein. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as an HDAC inhibitor and could cause hyperacetylation of histones, potentially leading to a reduction in MAGE-A9 expression through chromatin remodeling, thereby inhibiting the protein's function. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat inhibits HDAC, potentially leading to altered acetylation of histones, which could reduce MAGE-A9 expression by changing the chromatin environment, resulting in functional inhibition of the protein. | ||||||